Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder

Neuropsychopharmacology

Volumn 42, Issue 4, 2017, Pages 864-875

  Roy, Bhaskar ^a   Dunbar, Michael ^a   Shelton, Richard C ^a   Dwivedi, Yogesh ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AKT1 SUBSTRATE1 PROTEIN; CORTICOSTERONE; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FLUOXETINE; GLUCOCORTICOID RECEPTOR; GRIA3 PROTEIN; GRIA4 PROTEIN; HEAT SHOCK PROTEIN 90AB1; MESSENGER RNA; MICRORNA 124; MICRORNA 124 3P; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NR3C2 PROTEIN; PROTEIN; RNA INDUCED SILENCING COMPLEX; UNCLASSIFIED DRUG; MICRORNA; MIRN124 MICRORNA, HUMAN; MIRN124 MICRORNA, RAT;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 3; CONTROLLED STUDY; DNA BASE COMPOSITION; DNA METHYLATION; DOWN REGULATION; ECTOPIC EXPRESSION; ENZYME ACTIVITY; EPIGENETICS; GENETIC CONSERVATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NONHUMAN; PATHOGENESIS; PH; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; RAT; RNA ISOLATION; RNA SEQUENCE; STRESS; UPREGULATION; ADULT; ANIMAL; BLOOD; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; MENTAL STRESS; METABOLISM;

ADULT; ANIMALS; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; NEURONAL PLASTICITY; PREFRONTAL CORTEX; RATS; STRESS, PSYCHOLOGICAL;

EID: 84990178952     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2016.175     Document Type: Article

References (62)

1. Bahi A, Chandrasekar V, Dreyer JL (2014). Selective lentiviralmediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats. Psychoneuroendocrinology 46: 78-87.
2. Barbier E, Tapocik JD, Juergens N, Pitcairn C, Borich A, Schank JR et al (2015). DNA methylation in the medial prefrontal cortex regulates alcohol-induced behavior and plasticity. J Neurosci 35: 6153-6164.
3. Belmaker RH, Agam G (2008). Major depressive disorder. N Engl J Med 358: 55-68.
4. Beneyto M, Meador-Woodruff JH (2006). Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia. Synapse 60: 585-598.
5. Beneyto M, Meador-Woodruff JH (2008). Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 33: 2175-2186.
6. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G et al (2011). Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 9: 90.
7. Chandrasekar V, Dreyer JL (2009). microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 42: 350-362.
8. Devaux Y, Stammet P, Friberg H, Hassager C, Kuiper MA, Wise MP et al (2015). MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest? Crit Care 19: 54.
9. Duric V, Banasr M, Stockmeier CA, Simen AA, Newton SS, Overholser JC et al (2013). Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol 16: 69-82.
10. Dwivedi Y, Rizavi HS, Conley RR, Pandey GN (2006). ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 11: 86-98.
11. Dwivedi Y, Roy B, Lugli G, Rizavi H, Zhang H, Smalheiser NR (2015). Chronic corticosterone-mediated dysregulation of micro-RNA network in prefrontal cortex of rats: relevance to depression pathophysiology. Transl Psychiatry 5: e682.
12. Dwyer JM, Duman RS (2013). Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry 73: 1189-1198.
13. First M, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient edn. Biometric Research. New York State Psychiatric Institute: New York, NY, USA.
14. Fischbach SJ, Carew TJ (2009). MicroRNAs in memory processing. Neuron 63: 714-716.
15. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ (2011). miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6: 482-488.
16. Gascon E, Lynch K, Ruan H, Almeida S, Verheyden JM, Seeley WW et al (2014). Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia. Nat Med 20: 1444-1451.
17. Hall BS, Moda RN, Liston C (2015). Glucocorticoid mechanisms of functional connectivity changes in stress-related neuropsychiatric disorders. Neurobiol Stress 1: 174-183.
18. Hansen KF, Karelina K, Sakamoto K, Wayman GA, Impey S, Obrietan K (2013). miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct Funct 218: 817-831.
19. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC (1995). The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200: 151-154.
20. Jankord R, Herman JP (2008). Limbic regulation of hypothalamopituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 1148: 64-73.
21. Jin XF, Wu N, Wang L, Li J (2013). Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol 33: 601-613.
22. Jovicic A, Roshan R, Moisoi N, Pradervand S, Moser R, Pillai B et al (2013). Comprehensive expression analyses of neural cell-typespecific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci 33: 5127-5137.
23. Keene JD, Komisarow JM, Friedersdorf MB (2006). RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat Protoc 1: 302-307.
24. Kim VN (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
25. Labermaier C, Masana M, Muller MB (2013). Biomarkers predicting antidepressant treatment response: how can we advance the field? Dis Markers 35: 23-31.
26. Lai CY, Lee SY, Scarr E, Yu YH, Lin YT, Liu CM et al (2016). Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue. Transl Psychiatry 6: e717.
27. LaPlant Q, Vialou V, Covington HE 3rd, Dumitriu D, Feng J, Warren BL et al (2010). Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci 13: 1137-1143.
28. Li LC, Dahiya R (2002). MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
29. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
30. Lopez JP, Lim R, Cruceanu C, Crapper L, Fasano C, Labonte B et al (2014). miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat Med 20: 764-768.
31. Maffioletti E, Tardito D, Gennarelli M, Bocchio-Chiavetto L (2014). Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. Front Cell Neurosci 8: 75.
32. Maiorano NA, Mallamaci A (2010). The pro-differentiating role of miR-124: indicating the road to become a neuron. RNA Biol 7: 528-533.
33. Makeyev EV, Zhang J, Carrasco MA, Maniatis T (2007). The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27: 435-448.
34. Malki K, Pain O, Tosto MG, Du Rietz E, Carboni L, Schalkwyk LC (2015). Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Transl Psychiatry 5: e519.
35. Meador-Woodruff JH, Hogg AJ Jr., Smith RE (2001). Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res Bull 55: 631-640.
36. Medina A, Seasholtz AF, Sharma V, Burke S, Bunney W Jr., Myers RM et al (2013). Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J Psychiatr Res 47: 307-314.
37. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
38. Oka M, Rodic N, Graddy J, Chang LJ, Terada N (2006). CpG sites preferentially methylated by Dnmt3a in vivo. J Biol Chem 281: 9901-9908.
39. Ota KT, Liu RJ, Voleti B, Maldonado-Aviles JG, Duric V, Iwata M et al (2014). REDD1 is essential for stress-induced synaptic loss and depressive behavior. Nat Med 20: 531-535.
40. Rajasethupathy P, Fiumara F, Sheridan R, Betel D, Puthanveettil SV, Russo JJ et al (2009). Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 63: 803-817.
41. Sagata N, Iwaki A, Aramaki T, Takao K, Kura S, Tsuzuki T et al (2010). Comprehensive behavioural study of GluR4 knockout mice: implication in cognitive function. Genes Brain Behav 9: 899-909.
42. Salzman S, Endicott J, Clayton P, Winokur G (1983). Diagnostic evaluation after death (DEAD) NIMH. Neurosciences Research Branch: Rockville, MD, USA.
43. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E et al (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25: 903-915.
44. Scott HL, Tamagnini F, Narduzzo KE, Howarth JL, Lee YB, Wong LF et al (2012). MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci 36: 2941-2948.
45. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V (2004). Expression profiling of mammalian micro-RNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5: R13.
46. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22-33.
47. Sheinerman KS, Umansky SR (2013). Circulating cell-free micro-RNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7: 150.
48. Smalheiser NR, Lugli G, Rizavi HS, Torvik VI, Turecki G, Dwivedi Y (2012). MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One 7: e33201.
49. Smalheiser NR, Lugli G, Rizavi HS, Zhang H, Torvik VI, Pandey GN et al (2011). MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int J Neuropsychopharmacol 14: 1315-1325.
50. Smalheiser NR, Zhang H, Dwivedi Y (2014). Enoxacin elevates microRNA levels in rat frontal cortex and prevents learned helplessness. Front Psychiatry 5: 6.
51. Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG (2005). Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21: 1469-1477.
52. Spitzer RW, Gibbon M, First MD (1995). Structural Clinical Interview for DSM-IV (SCID) Biometrics Research. New York State Psychiatric Institute: New York, NY, USA.
53. Sprengel R (2006). Role of AMPA receptors in synaptic plasticity. Cell Tissue Res 326: 447-455.
54. Tsujiura M, Komatsu S, Ichikawa D, Shiozaki A, Konishi H, Takeshita H et al (2015). Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer 18: 271-279.
55. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A et al (2015). Proteomics. Tissue-based map of the human proteome. Science 347: 1260419.
56. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524.
57. Vreugdenhil E, Verissimo CS, Mariman R, Kamphorst JT, Barbosa JS, Zweers T et al (2009). MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 150: 2220-2228.
58. Walker RM, Rybka J, Anderson SM, Torrance HS, Boxall R, Sussmann JE et al (2015). Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder. J Psychiatr Res 62: 48-55.
59. Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN et al (2007). Predictors of attrition during initial (citalopram) treatment for depression: a STAR∗D report. Am J Psychiatry 164: 1189-1197.
60. Wei Q, Fentress HM, Hoversten MT, Zhang L, Hebda-Bauer EK, Watson SJ et al (2012). Early-life forebrain glucocorticoid receptor overexpression increases anxiety behavior and cocaine sensitization. Biol Psychiatry 71: 224-231.
61. Yuen EY, Wei J, Liu W, Zhong P, Li X, Yan Z (2012). Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron 73: 962-977.
62. Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang SL, Dai B et al (2011). Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 71: 326-331.